Secteur Anavex Life Sciences Corp.

Actions

AVXL

US0327973006

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 15:36:51 15/07/2026 Varia. 5j. Varia. 1 janv.
2,430 USD 0,00% Graphique intraday de Anavex Life Sciences Corp. -10,33% -31,74%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
0,00%-10,33%-2,80%-22,12%-31,74%-78,83%-71,14%-89,64%-64,26% 225 M
-1,47%-6,23%-1,47%+5,63%+4,63%+55,93%+71,39%+193,31%+5 497,01% 54,49 Md
+6,05%+7,79%+27,88%+19,67%+40,68%+62,23%+88,46%-20,90% - 55,93 Md
-0,68%-2,42%+12,53%-28,22%-36,73%+8,07%+434,51%+302,01%+892,88% 23,87 Md
-0,64%-4,13%-0,15%-8,14%-5,04%-18,56%-16,48%-57,36% - 22,86 Md
+3,51%+10,88%+27,88%+6,86%+25,76%+44,84%-3,21%-71,29% - 20 Md
+1,10%+0,24%+18,98%+3,13%-6,44%+39,35%-29,39%-30,40%+66,07% 17,48 Md
-4,00%-10,96%+40,27%+107,34%+183,22%+181,91%+328,17%+1 580,55%+601,13% 15,39 Md
+7,69%+11,91%+27,98%+3,37%+36,79%+50,03%+720,96% - - 15,19 Md
-1,63%-2,30%+4,97%+21,61%+27,24%+22,36%+187,62%+218,87%+578,47% 14,02 Md
-1,49%-1,56%+11,67%+2,26%-7,81%+67,84%+137,79%+458,71% - 12,38 Md
-0,94%-2,58%+10,42%-25,80%-11,55%-39,09%+622,90%+116,97%+114,56% 12,01 Md
+7,98%+7,25%+15,84%-29,78%-8,41%-14,25%+182,02%+73,51% - 11,26 Md
-1,79%-4,24%+16,79%+23,48%+28,94%+112,36%+134,55%+341,91%+744,64% 11,12 Md
-1,68%-17,32%-3,50%+7,83%+8,31%+286,41%+107,83%+14,98%+1 198,01% 10,13 Md
+0,02%+0,15%+0,58%+18,03%+23,23%+46,54%+199,13% - - 9,83 Md
+4,24%+3,24%+19,20%-27,30%+19,44%+23,21%+100,47%-21,82% - 9,25 Md
+0,08%+0,22%+142,85%+110,59%+79,83%+153,51%+310,95%+324,28% - 8,83 Md
-2,97%+5,01%+22,48%+54,59%+202,05%+502,99%+608,05%-43,54%-14,88% 8,7 Md
-1,33%-7,35%+18,44%-10,44%+21,82%+54,51%+13,24%+163,03% - 8,12 Md
Moyenne +0,63%-2,03%+20,54%+11,63%+29,71%+78,07%+206,39%+191,84%+961,36% 17,05 Md
Moyenne pondérée par Capi. +1,12%-0,54%+18,08%+11,01%+25,85%+67,26%+180,97%+177,65%+2 156,23%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action AVXL
  4. Secteur Anavex Life Sciences Corp.